アトピー性皮膚炎モデルの病変部角化細胞において、デキサメサゾンはTNF-αにより誘導されたTSLPの発現を抑制するがタクロリムスは抑制しない [PDF]
Mizuno, Kazuko
core
Emerging Therapeutic Strategies in Asthma: Advances in Treatment, Drug Delivery, Drug Adherence, and Disease Management. [PDF]
Lim YX +7 more
europepmc +1 more source
What is new on the horizon for the biologics world: New kids of the block - WAO state of art. [PDF]
Canonica GW +27 more
europepmc +1 more source
Asthma biologic effectiveness by age and sex in the US CHRONICLE study. [PDF]
Baptist AP +7 more
europepmc +1 more source
Verekitug, a Novel Antibody Antagonist to the TSLP Receptor in Adults with Asthma: A 32-Week Randomized Phase 1b Multiple Ascending-Dose Trial. [PDF]
Singh D +9 more
europepmc +1 more source
Global research trends in airway epithelial cell immune responses: a bibliometric study. [PDF]
He J +6 more
europepmc +1 more source
Epidermal NAD+ deficiency induces IL-36-mediated skin inflammation and acanthosis. [PDF]
Seki T +8 more
europepmc +1 more source
Safety, Tolerability, and Pharmacokinetics of HBM9378 (SKB378/WIN378), a Fully Human IgG1 Monoclonal Antibody Against TSLP After Single Ascending Doses in Chinese Healthy Subjects. [PDF]
Yang X +9 more
europepmc +1 more source
Transient Receptor Potential (TRP) Channels as Fundamental Regulators of Fibrosis and Pruritus-A New Therapeutic Target for Pathological Scar Management. [PDF]
Tang Y, Zhang Z, Zhang Y.
europepmc +1 more source

